Pavmed Inc. (NSDQ:PAVM) today offered to trade a pair of its just-sold Series W warrants for a single Series Z unit worth $5.oo apiece.
The New York-based company previously offered the opportunity for investors to exercise the Series W warrants at a discounted price of $2.00 per share. As of Feb. 8, Pavmed said 34,345 Series W warrants had been tendered for exercise and the company had raised $68,690 in gross cash proceeds.
Get the full story at our sister site, Drug Delivery Business News.
The post Pavmed floats exchange offer for discounted Series W shares appeared first on MassDevice.
from MassDevice http://ift.tt/2nTk8qm
Cap comentari:
Publica un comentari a l'entrada